Both systemic sclerosis and systemic lupus erythematosus have down-regulated RGS5, but they also have distinctive genetic expression profiles.

Patients with SSc vs controls showed a greater prevalence of WMH on brain MRIs, particularly in deep white matter regions.

A 28-year-old woman was admitted to the hospital because of severe hypoxemia and right heart failure that had been caused by rapidly progressive pulmonary hypertension. A diagnosis was made.

Pivotal Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First Line (1L) Consolidation in Large B-Cell ...

Clinical trial timelines for key lymphoma and autoimmune disease programs were delayed by approximately two quarters. Cash and investments totaled $302.6 million at the end of Q2 2025, expected to ...

Initial update for NKX019 in multiple autoimmune indications expected in second half of 2025Cash balance of $334.0 million on June 30, 2025, including cash, cash equivalents and investments, expected ...

Novartis announces positive results from VAYHIT2 phase III trial of ianalumab plus eltrombopag in patients with primary immune thrombocytopenia: Basel Wednesday, August 13, 2025, ...

GAAP revenue was $2.7 million for Q2 2025, missing analyst estimates by 20.6%. Operating expenses surged, driven by costs tied to the ACELYRIN merger and clinical trial acceleration. The merger ...

Alumis continues to leverage its proprietary data analytics and research platform to advance discovery programs that target key drivers of immune-mediated diseases. In addition to its two ...

Join us for an uplifting and insightful episode of the Caregiver Relief Podcast with special guest Janet Kuebler, a certified ...